## Abstract Twentyβnine elderly patients who failed treatment with clozapine, risperidone, or olanzapine entered this 24βweek, singleβcenter, openβlabel trial to assess the efficacy of quetiapine (12.5β400 mg/day) for psychosis in patients with Parkinson's disease (PD). Psychiatric, motor, and cogn
Psychotic and compulsive symptoms in Parkinson's disease
β Scribed by Dagmar Verbaan; Stephanie M. van Rooden; Martine Visser; Johan Marinus; Murat Emre; Jacobus J. van Hilten
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 82 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The objective of this study is to evaluate psychiatric symptoms in Parkinson's disease (PD) patients and to assess their relation with other clinical aspects of PD. Psychotic symptoms (PS) and compulsive symptoms (CS) as well as other nonmotor and motor features were evaluated in 353 PD patients. Psychotic and compulsive symptom scores did not correlate significantly. PS occurred in 65% of patients, with item frequencies ranging from 10% (paranoid ideation) to 55% (altered dream phenomena). Regression analysis showed that autonomic impairment accounted for 20% of the 32% explained variance of PS, whereas cognitive problems, depression, daytime sleepiness, and dopamine agonist (DA) dose explained the rest. CS occurred in 19%, with item frequencies of 10% for both sexual preoccupation and compulsive shopping/gambling. Patients with more severe CS (score β₯ 2 on one or both items) were significantly more often men, had a younger age at onset, a higher DA dose and experienced more motor fluctuations compared to the other patients. PS and CS are common but unrelated psychiatric symptoms in PD. The relations found between PS and cognitive problems, depression, daytime sleepiness, and autonomic impairment suggests a resemblance with Dementia with Lewy Bodies. The prominent association between PS and autonomic impairment may be explained by a shared underlying mechanism. Our results confirm previous reports on the profile of patients developing CS, and mechanisms underlying motor fluctuations may also play a role in the development of CS in PD. Β© 2009 Movement Disorder Society
π SIMILAR VOLUMES
## Abstract Our aim was to examine diseaseβrelated and genetic correlates of the development of psychotic symptoms in a large population of patients with Parkinson's disease. We studied 500 patients with Parkinson's disease from the NeuroGenetics Research Consortium using logistic regression models
The case notes of 37 patients with neuropathologically confirmed Alzheimer's disease were studied for non-cognitive psychiatric features occurring during the course of the illness. Four (1 YO) exhibited delusions, five (14%) had visual hallucinations and one (3%) had auditory hallucinations. Two (6%
## Abstract Visual symptoms are common in PD and PD dementia and include difficulty reading, double vision, illusions, feelings of presence and passage, and complex visual hallucinations. Despite the established prognostic implications of complex visual hallucinations, the interaction between cogni
## Abstract Antiparkinson therapy can be the primary cause of a range of nonmotor symptoms that include a set of complex disinhibitory psychomotor pathologies and are linked by their repetitive, reward or incentiveβbased natures. These behaviors relate to aberrant or excessive dopamine receptor sti
In their excellent review of neuropsychiatric problems in Parkinson's disease (PD), 1 the authors made one small error but more importantly raised an interesting question about drug trials. Also, as they wrote their article, both melperone (personal communication) and pimavanserin, 2 subjected to ra